X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


最新的帖子

一月 06, 2020

The NovaPure® Component Portfolio – Solution for Lifecycle Management

It is essential to consider lifecycle management during the development of new drugs &ndash; especially in the evolving area of biologic drugs. The market demand for both ease of use, and patient-centric at-home administration, is driving the need for innovative container systems and delivery devices. Typically, drugs are launched in vials; continuous development often then enables launch in other formats, such as pre-filled syringes and cartridges. West is committed to easing this movement from container systems to delivery devices through its NovaPure<sup>&reg;</sup> component portfolio of elastomer closures. NovaPure stoppers and plungers offer best performance and highest quality. Developed with Quality-by-Design principles, they use FluroTec<sup>&reg;</sup> barrier film and B2 coating technologies.
Cathy Chhour

Cathy Chhour

Sr. Technical Account Specialist, TCS, NA

以前的博客
Fluoropolymer

十二月 06, 2019

Advantages of Fluoropolymer-Laminated Components

Candice Sun

Candice Sun

Specialist, Scientific Affairs, CN

Daikyo Crystal Zenith Insert Needle Syringe

七月 10, 2019

Intended Use and Packaging Risks for Compounding Pharmacies (503Bs)

Amy Kim

Amy Kim

Sr. Specialist, Scientific Communications, SA & TS

CPhI China Tradeshow

六月 20, 2019

West Helps Simplify the Journey™ in China

Jessie Zhang

Jessie Zhang

Manager, Global Communications, AP

Integrated Solutions Program

五月 16, 2019

Delivering Macromolecules: Challenges Associated with the Delivery of Biologic Drugs

Victoria Morgan

Victoria Morgan

Director, Segment Marketing, Biologics

Introducing Integrated Solutions

五月 02, 2019

FDA Guidance Affecting cGMP Compounding Pharmacies (503Bs)

Amy Kim

Amy Kim

Sr. Specialist, Scientific Communications, SA & TS

Load more